Protocol summary

Study aim
Determination of the effectiveness of low-dose ketamine with dexmedetomidine, and its comparison with morphine in controlling pain in patients with limb trauma referred to the emergency department
Design
Clinical trial, with a parallel-group, double-blind, randomized, phase 3 on 258 patients. Using Block Stratified Randomization software, Windows version 6.0 is randomly divided into two categories.
Settings and conduct
258 adult patients who were referred to the emergency department with pain due to limb trauma are randomly divided into two groups. After obtaining informed consent to participate in the study, they receive the drugs, then by comparing the scores they have suffered before and after taking the drug (at intervals of 5, 10, and 15 minutes after injecting the drug) and We will also discuss the possible benefits of this alternative method for its side effects.
Participants/Inclusion and exclusion criteria
Adult patients who have been referred to the Sina Hospital emergency department with limb trauma. Patients with the following characteristics will not be included in the study 1. Pain score ≤ 5, 2. Pregnancy and post-partum women, 3. Altered mental status, 4. Allergy to ketamine or morphine or dexmedetomidine, 5. Bodyweight ≤ 46 kg or ≥ 115, 6. Unstable vital signs: BP≤ 90 mmHg or ۸ 180 mmHg, PR≥150 or ≤50 bits/min, RR≤10 or ≥30, 7. History of the recent head or eye trauma, 8. History of seizure, 9. History of elevated ICP, 10. Chronic pain, ۱۱. Renal or hepatic failure, 12. Substance or alcohol abuse, 13. Documented psychiatric disorders, 14. Opium addiction, 15. Recent use of narcotic analgesics
Intervention groups
Two groups of intravenous sub dissociative ketamine (0.3 mg/kg) with (1 mcg/kg) intravenous dexmedetomidine or intravenous morphine (0.1 mg/kg).
Main outcome variables
Pain intensity; blood pressure; heartbeat; Number of breaths; drug side effects; rescue analgesia

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220120053770N1
Registration date: 2022-02-12, 1400/11/23
Registration timing: prospective

Last update: 2022-02-12, 1400/11/23
Update count: 0
Registration date
2022-02-12, 1400/11/23
Registrant information
Name
MohammadMatin Moradi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 6691 0317
Email address
mmatinmoradi@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-04-03, 1401/01/14
Expected recruitment end date
2023-03-20, 1401/12/29
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the efficacy of low-dose (sub dissociative) ketamine with dexmedetomidine, and its comparison with morphine in controlling pain in patients with limb trauma referred to emergency department of Sina hospital
Public title
Evaluation of the effectiveness of low-dose ketamine (Sub dissociative) with dexmedetomidine in controlling pain in patients with limb trauma referred to emergency department
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Adult patients (older than 18 years old) gave pain more than five points limb trauma pain obtaining the informed consent
Exclusion criteria:
Pain score ≤5 Pregnancy and post-partum women Altered mental status Allergy to ketamine or fentanyl Body weight ≤ 46 kg or ≥ 115 Unstable vital signs: BP≤ 90 mmHg or ≥ 180 mmHg , PR≥150 or ≤50 bits/min , RR≤10 or ≥30 History of recent head or eye trauma History of Siesure History of elevated ICP Chronic pain Renal or hepatic failure Substance or alcohol abuse Documented psychiatric disorders Opium addiction Recent use of narcotic analgesics
Age
From 18 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Investigator
  • Outcome assessor
Sample size
Target sample size: 258
Randomization (investigator's opinion)
Randomized
Randomization description
Patients have already been randomly divided into two categories by a statistician using Block Stratified Randomization Windows version 6.0 software, and their randomization list has been provided to the researcher. Each day five participants from those two groups will be involved and they will be ordered randomly . Every morning a person not involved in the study or patient care prepared study packages and stored them in a locked drawer. When each new subject was enrolled by an attending emergency physician, they were allocated to the next number based on the randomization schedule. The physician then picked up the matched, numbered package from the drawer.
Blinding (investigator's opinion)
Double blinded
Blinding description
In this study, the patient does not know the type of drug used. Also, to observe the principle of blinding in the study, the researcher and the person who follows and records the patient's pain are two different people, ie one person enters the patient and follows and another person selects and prescribes the patient's medication. The person following the patient will not be aware of the medication the patient has taken.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Research Ethics Committees of Sina Hospital
Street address
Sina Hospital
City
Tehran
Province
Tehran
Postal code
1136746911
Approval date
2022-01-17, 1400/10/27
Ethics committee reference number
IR.TUMS.SINAHOSPITAL.REC.1400.117

Health conditions studied

1

Description of health condition studied
Pain management of limb trauma in emergency department
ICD-10 code
G89.11
ICD-10 code description
Acute pain due to trauma

Primary outcomes

1

Description
pain numerical rating scale
Timepoint
Intervals of 5, 10, 15, 30 minutes
Method of measurement
requires the patient to rate their pain (0–10) where 0 is no pain and 10 is the worst pain imaginable

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: Intravenous ketamine with sub dissociative dose (0.3 mg / kg) with intravenous dexmedetomidine (1 mcg / kg)
Category
Treatment - Drugs

2

Description
Intervention group: Intravenous morphine (0.1 mg / kg)
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Sina Hospital
Full name of responsible person
MohammadMatin Moradi
Street address
Sina Hospital
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6634 8500
Email
hosp_sina@sina.tums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
حسین قناعتی
Street address
Tehran University of Medical Science
City
Tehran
Province
Tehran
Postal code
1417613151
Phone
+98 21 6405 3334
Email
okazi@tums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tehran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Alireza Baratloo
Position
Research Associate
Latest degree
Specialist
Other areas of specialty/work
Emergency Medicine
Street address
Sina Hospital
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6634 8500
Email
arbaratloo@sina.tums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Alireza Jalali
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Emergency Medicine
Street address
Sina Hospital
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6634 8500
Email
a.jalall85@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
MohammadMatin Moradi
Position
Medical Student
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Sina Hospital
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6634 8500
Email
mmatinmoradi@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
All collected data will be available
When the data will become available and for how long
6 months after publication
To whom data/document is available
Data will be available for Academic researchers and scientists
Under which criteria data/document could be used
Statistical analysis of data
From where data/document is obtainable
contact mmatininmoradi@yahoo.com
What processes are involved for a request to access data/document
After receiving the application, the requested information will be provided within one month
Comments
Loading...